Ben Goldacre on more bad data: this time from drug companies

By Carl Zimmer | September 30, 2012 10:47 am

This morning I was accused of writing “corporate sponsored blogs whoring themselves out to all and sundry.” Actually, I was arguing that science writers have a duty to call out weak science and press manipulation rather than cave into it. That applies to any kind of research. I happened to be talking about research on genetically modified foods and their health risks. But it applies just as well to pharmaceutical corporations that deep-six drug trials that don’t support their drugs. The most eloquent critic of this bad behavior is Ben Goldacre. You can watch this video of a TED talk he recently gave on the subject, read this essay in the Guardian, or pre-order his new book, Bad Pharma.

If highlighting Goldacre’s vital work means I have to return my gold-plated corporate-whore Corvette, so be it.

[Update: Guardian link fixed, book title fixed]

CATEGORIZED UNDER: Link Love, Meta
ADVERTISEMENT

Comments are closed.

NEW ON DISCOVER
OPEN
CITIZEN SCIENCE
ADVERTISEMENT

Discover's Newsletter

Sign up to get the latest science news delivered weekly right to your inbox!

The Loom

A blog about life, past and future. Written by DISCOVER contributing editor and columnist Carl Zimmer.

About Carl Zimmer

Carl Zimmer writes about science regularly for The New York Times and magazines such as DISCOVER, which also hosts his blog, The LoomHe is the author of 12 books, the most recent of which is Science Ink: Tattoos of the Science Obsessed.

ADVERTISEMENT

See More

ADVERTISEMENT
Collapse bottom bar
+